MAPK14 and neoplasm: Despite the early promising findings, a major concern associated with this therapeutic approach is the fact that p38 is a well-recognized tumor suppressor (198), suggesting the need to balance any beneficial effects on tumor angiogenesis against potentially damaging actions on the tumor itself.